CC-99282
Showing 1 - 25 of 786
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
- Obinutuzumab
- CC-99282
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)
Not yet recruiting
- Relapsed or Refractory T-cell Lymphomas
-
Sendai-shi, Miyagi, JapanLocal Institution - 0001
Sep 12, 2023
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)
Recruiting
- Lymphoma, Non-Hodgkin
- CC-99282
- +4 more
-
Los Angeles, California
- +86 more
Jan 23, 2023
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023
Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)
Not yet recruiting
- Advanced Solid Tumors
-
Madrid, M, Spain
- +1 more
Dec 23, 2022
Risk Behaviors in Adolescents With Chronic Diseases
Recruiting
- Chronic Disease
- Somatic Disorders
- Questionnaire risk behaviors in adolescents with chronic diseases
-
Paris, FranceRobert Debre Hospital
Mar 20, 2023
Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)
Recruiting
- Prostate Cancer Recurrent
- CC-1 Infusion
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jan 10, 2023
Chronic Constipation Trial in Lanzhou, Shenzhen, Xi'an (taVNS, Laxative Agent)
Recruiting
- Chronic Constipation
- taVNS
- Laxative Agent
-
Lanzhou, Gansu, China
- +4 more
Feb 9, 2023
Smoking Trial in Kajetany (CHTP 1.0, Conventional Cigarette (CC))
Completed
- Smoking
- CHTP 1.0
- Conventional Cigarette (CC)
-
Kajetany, PolandBioVirtus Research Site Sp. z o.o.
Jan 26, 2023
Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)
Recruiting
- Healthy Volunteers
- CC-92480
- +4 more
-
Dallas, TexasCovance Clinical Research Unit - Dallas
Oct 25, 2022
Cigarette Smoking Trial in New York (E-cigarette (EC), Nicotine Replacement Therapy (NRT), Harm-Reduction Counseling)
Not yet recruiting
- Cigarette Smoking
- E-cigarette (EC)
- +3 more
-
New York, New YorkNYU Langone Health
Apr 4, 2023
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
-
Borddeaux Cedex, France
- +9 more
Nov 11, 2022